Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment
Title:
Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment
Author:
Wessels, A. Mireille A. Elzinga, Femke A. Koppelman, Gerard H. Akkerman, Onno W. Mian, Paola Touw, Daan J.
Appeared in:
Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences